Clinical Trials Sponsored by MedVadis Research Corporation

Total 718 results

MedVadis Research Corporation

Completed

Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive Functioning

Chronic Pain

United States
MedVadis Research Corporation

Completed

Effect of Intranasal Oxytocin on Headache in Chronic Daily Headache

Chronic Daily Headache

United States
MedVadis Research Corporation
Sepracor Incorporated, 84 Waterford Drive, Marlborough, MA 01752

Completed

Treatment of Insomnia in Migraineurs

Migraine | Insomnia
Medaxis, LLC
Professional Education and Research Institute

Recruiting

A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot

Diabetic Foot | Diabetic Foot Ulcer

United States
Pope Research Corporation

Unknown

Cimzia Treatment in Rheumatoid Arthritis: Randomizing to Stop Versus Continue Disease-modifying Anti-rheumatic Drug(s)

Rheumatoid Arthritis

Canada
Epitopoietic Research Corporation

Not yet recruiting

ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab

Glioma, Malignant

Thailand
Bioelectric Research Corporation

Unknown

Microcurrent Stimulation Reduces Post-Operative Swelling and Healing Time Following Knee Replacement Surgery

Wounds and Injuries | Edema | Osteoarthritis of Knee

United States
Incyte Corporation
Innovaderm Research

Completed

Study of Ruxolitinib Cream in Children With Atopic Dermatitis

Atopic Dermatitis

United States
American Research Corporation
AbbVie

Completed

A Study to Investigate HCV Response Rates in Real World Patients: HEARTLAND Study (HEARTLAND)

Chronic Hepatitis C
Pope Research Corporation
Amgen

Withdrawn

Psoriatic Arthritis Treat to Target vs. Usual Care (PRC-05-2011)

Psoriatic Arthritis (PsA)

Canada
TearLab Corporation
Alcon Research

Completed

TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease (CVS)

Keratoconjunctivitis Sicca

United States, Spain, France, Germany, United Kingdom
Silver Lake Research Corporation

Unknown

Evaluation of HemoTypeSC as a Novel Rapid Test for Point-of-Care Screening for Sickle-Cell Disease, Hemoglobin C Disease, and Carrier Status in Low-Resource Settings

Diagnoses Disease

United States
Electrophysiology Research Foundation
Axio Research Corporation

Terminated

EdoxabaN or Warfarin Therapy In Device Procedures in Patients With Non-Valvular Atrial Fibrillation (ENTICED-AF)

Atrial Fibrillation

United States
Ottawa Heart Institute Research Corporation

Recruiting

Blood Flow Reserve: Effects After Training With Heavy Inspiratory Exercises (BREATHE)

Coronary Artery Disease

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Feasibility of High-Intensity Interval Nordic Walking in Patients With Coronary Artery Disease (HIIT-NoW)

Coronary Artery Disease

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Evaluating the Use of a Remote Telehome Monitoring Hypertension Program for Patients Receiving Virtual Care (HTMTHM)

Hypertension

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Pilot Randomized Clinical Trial of Live-streamed Cardiovascular Rehabilitation (VirtualEX)

Cardiac Disease

Canada
Ottawa Heart Institute Research Corporation

Recruiting

A Randomized Trial of Lenient Versus Strict Arm Instruction Post Cardiac Device Surgery (LENIENT)

Post-Op Complication

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus (LACLOT)

Atrial Fibrillation

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Healing Hearts Together: Evaluating a Couples-based Intervention to Improve Health Outcomes

Cardiovascular Diseases

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion (CAPITAL-RAPTOR)

Radial Artery Occlusion

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Circulating BDNF in Patients With Atrial Fibrillation Undergoing Catheter Ablation or Exercise Training (NEURO-AF)

Atrial Fibrillation

Canada
Ottawa Heart Institute Research Corporation

Completed

The Effect of High-Intensity Interval Training on Glucose Variability and Atrial Fibrillation Symptoms (Glucose-AF)

Atrial Fibrillation | Type 2 Diabetes

Canada
Ottawa Heart Institute Research Corporation

Completed

Exercise Training in Women With Heart Disease (EXCEED)

Cardiovascular Diseases | Coronary Heart Disease

Canada
Ottawa Heart Institute Research Corporation

Active, not recruiting

Impact of Preoperative FFR on Arterial Bypass Graft Functionality (IMPAG)

Heart Disease

Canada, Belgium
Ottawa Heart Institute Research Corporation

Active, not recruiting

The RAPID COVID-19 TRIAGE Algorithm

COVID-19

Canada
Ottawa Heart Institute Research Corporation

Active, not recruiting

Barrier-Protect Study

Infection

Canada
HonorHealth Research Institute
Incyte Corporation

Withdrawn

Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas

Pancreas Cancer

United States
Ottawa Heart Institute Research Corporation

Active, not recruiting

IMAGE-HF: Project IIa Canadian CArdiomyopathy Registry for Device Therapy (CanCARD-MR)

Heart Failure
Ottawa Heart Institute Research Corporation

Completed

Spironolactone Therapy in Chronic Stable Right HF Trial (STAR-HF)

Pulmonary Arterial Hypertension | Pulmonary Hypertension, Primary, 4 | Chronic Right-Sided Heart Failure | Pulmonary Hypertension, Primary, 2 | Pulmonary Hypertension, Primary, 3 | Cardiomyopathy Right Ventricular

Canada
Ottawa Heart Institute Research Corporation

Withdrawn

Surgical PA-LAA Shunting: a Feasibility Study (PA-LAA)

LAA Thrombus Prevention

Canada
Ottawa Heart Institute Research Corporation

Completed

Evaluation of the Ottawa Model for Smoking Cessation in Diabetes Education Programs (OMSCinDEP)

Pre-diabetic | Diabetic Type II Mellitus

Canada
Ottawa Heart Institute Research Corporation

Completed

Mild Versus Moderate Therapeutic Hypothermia in Out-of-hospital Cardiac Arrest Patients (CAPITALCHILL)

Cardiac Arrest

Canada
DeNova Research
Baxter Healthcare Corporation

Completed

A Study Evaluating the Efficacy and Safety of ARTISS Human Fibrin Sealant as Used in External Rhinoplasty

Subjects Requesting and Requiring an Open Rhinoplasty

United States
Ottawa Heart Institute Research Corporation

Terminated

Sleep to Your Heart's Content - Insomnia Intervention for Cardiac Patients

Cardiovascular Diseases | Insomnia

Canada
Ottawa Heart Institute Research Corporation

Terminated

A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)

Percutaneous Coronary Intervention | Ticagrelor | Antiplatelet Therapy | Stable Coronary Syndrome

Canada
Matrivax Research and Development Corporation

Completed

Safety and Immunogenicity of Typhax, a Typhoid Vaccine

Typhoid Fever
Ottawa Heart Institute Research Corporation

Completed

Decision Support for Adults Facing Implantable Cardioverter-Defibrillator Pulse Generator Replacement

Cardiovascular Diseases | Death, Sudden | Death, Sudden, Cardiac

Canada
Ottawa Heart Institute Research Corporation

Terminated

A Pilot Study Evaluating Heart and Lung Metabolism in Pulmonary Hypertension Associated With Left Heart Disease

Pulmonary Hypertension

Canada
Tuscaloosa Research & Education Advancement Corporation

Withdrawn

Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade

PTSD | Posttraumatic Stress Disorder

United States
Baylor Research Institute
Masimo Corporation

Unknown

Improved Patient Safety Through Continuous Bi-channel RR and SpO2 Monitoring With Masimo Patient SafetyNet (SafetyNet)

Signs and Symptoms, Respiratory
Tuscaloosa Research & Education Advancement Corporation

Terminated

Divalproex vs. Lamotrigine for Bipolar Disorder

Bipolar Disorder
Ottawa Heart Institute Research Corporation

Terminated

Multi-modality Imaging of Ischemia With 18F-FDG PET and CTA

Myocardial Ischemia

Canada
Ottawa Heart Institute Research Corporation

Completed

Ticagrelor vs Clopidogrel Effect on MFR in CAD Population (PATH)

Coronary Artery Disease

Canada
Ottawa Heart Institute Research Corporation

Terminated

Study to Develop a Non-invasive Marker for Monitoring Myocardial Fibrosis (SCAR)

Acute Coronary Syndrome | Hypertrophic Cardiomyopathy

Canada
Ottawa Heart Institute Research Corporation

Completed

Prognostic Value of Stress SPECT Myocardial Perfusion Imaging With Half Dose 99mTc-Tetrofosmin

Cardiovascular Disease

Canada
Cognitive Research Corporation
Novartis Pharmaceuticals

Withdrawn

Exploratory Study Evaluating the Effects of Darifenacin on Nocturia, Sleep and Daytime Wakefulness

Nocturia
Ottawa Heart Institute Research Corporation

Completed

The Role of Vitamin D in the Pathophysiology of Chronic Failure

Vitamin D Deficiency | Chronic Heart Failure

Canada
Ottawa Heart Institute Research Corporation

Completed

Accuracy of Half of the Usual Radiotracer Dose in SPECT (SPECT-Light)

Coronary Artery Disease

Canada
Ottawa Heart Institute Research Corporation

Completed

Integrating the "Ottawa Model" for Smoking Cessation Into Primary Care Practice (RCT-OMSC-PC)

Smoking Cessation

Canada

Clinical Trials Sponsored by MedVadis Research Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations